Coronavirus Test of Trump-Touted Malaria Drug May Report in July - ( via NewsPoints Desk)

  • Results from trials of hydroxychloroquine touted as a potential tool in the fight against the coronavirus may be ready in July, as reported on Sunday.

  • Novartis CEO Vas Narasimhan said the company expects to present results from a US study of the drug, as well as for two other drugs being tested for COVID-19 effectiveness -- Ilaris and Jakavi.

  • Novartis is ready to ramp up production of hydroxychloroquine, Narasimhan said, adding that existing studies of the drug did not meet the highest standard of clinical research.

To read more NewsPoints articles, click here.